Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe A Bilodeau

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
American Journal of Physiology. Cell Physiology|August 12, 2016
The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulationPhilippe A Bilodeau, Erin S Coyne, Simon S Wing
Journal of Clinical Medicine|April 9, 2024
The Impact of Anti-Amyloid Immunotherapies on Stroke CarePhilippe A Bilodeau, John R Dickson, Mariel G Kozberg
Multiple Sclerosis and Related Disorders|January 23, 2026
Low prevalence of inflammatory bowel disease among patients with seropositive neuromyelitis optica spectrum disorder in two large referral centersCarolyn Akers, Philippe A Bilodeau, Mattia Wruble Clark, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 6, 2026
Fulminant Amyloid β-Related Angiitis With Herniation and Rapid Response to Tocilizumab: A Case ReportJames V Nguyen, Emma M Byrne, Salina Yuan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2024
CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentationNatalia Drosu, Monique Anderson, Philippe A Bilodeau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2019
MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum settingPhilippe A Bilodeau, Vinayak Kumar, Andrew E Rodriguez, et al.
Journal of the Neurological Sciences|February 9, 2024
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, et al.
The Journal of Infectious Diseases|January 6, 2026
A threshold in anti-EBNA-1 antibody titers distinguishes salivary EBV shedders from non-sheddersJoão Vitor Mahler, Philippe A Bilodeau, Monique Anderson, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Neuropsychologic impact of MOGAD: A patient reported outcomes studyBruna Leles, Yihan Zhang, Philippe A Bilodeau, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 6, 2026
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying TreatmentsPhilippe A Bilodeau, Mattia Wruble Clark, Avanteeka Ganguly, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
American Journal of Physiology. Cell Physiology|August 12, 2016
The ubiquitin proteasome system in atrophying skeletal muscle: roles and regulationPhilippe A Bilodeau, Erin S Coyne, Simon S Wing
Journal of Clinical Medicine|April 9, 2024
The Impact of Anti-Amyloid Immunotherapies on Stroke CarePhilippe A Bilodeau, John R Dickson, Mariel G Kozberg
Multiple Sclerosis and Related Disorders|January 23, 2026
Low prevalence of inflammatory bowel disease among patients with seropositive neuromyelitis optica spectrum disorder in two large referral centersCarolyn Akers, Philippe A Bilodeau, Mattia Wruble Clark, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 6, 2026
Fulminant Amyloid β-Related Angiitis With Herniation and Rapid Response to Tocilizumab: A Case ReportJames V Nguyen, Emma M Byrne, Salina Yuan, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2024
CD4 T cells restricted to DRB1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentationNatalia Drosu, Monique Anderson, Philippe A Bilodeau, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 18, 2019
MOG-IgG myelitis coexisting with systemic lupus erythematosus in the post-partum settingPhilippe A Bilodeau, Vinayak Kumar, Andrew E Rodriguez, et al.
Journal of the Neurological Sciences|February 9, 2024
Predictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD)Negar Molazadeh, Philippe A Bilodeau, Rebecca Salky, et al.
The Journal of Infectious Diseases|January 6, 2026
A threshold in anti-EBNA-1 antibody titers distinguishes salivary EBV shedders from non-sheddersJoão Vitor Mahler, Philippe A Bilodeau, Monique Anderson, et al.
Multiple Sclerosis and Related Disorders|December 20, 2025
Neuropsychologic impact of MOGAD: A patient reported outcomes studyBruna Leles, Yihan Zhang, Philippe A Bilodeau, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 6, 2026
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying TreatmentsPhilippe A Bilodeau, Mattia Wruble Clark, Avanteeka Ganguly, et al.
Pageof 2